Stock Events

Stock Events

Biora Therapeutics 

€3.06
0
-€0.31-9.33% Thursday 07:04

Statistics

Day High
3.06
Day Low
3.06
52W High
3.06
52W Low
3.06
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
-2.66
-2.32
-1.99
-1.66
Expected EPS
-2.6558
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4ZU.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap113.59B
Vertex Pharmaceuticals focuses on creating new possibilities in medicine to cure diseases and improve people's lives, similar to Biora's mission in therapeutic areas.
Gilead Sciences
GILD
Mkt Cap166.9B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas overlapping with Biora's therapeutic interests.
AMGEN
AMGN
Mkt Cap181.77B
Amgen is a biotech company focusing on human therapeutics, with a product portfolio that could compete with Biora's developments in specific therapeutic areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap64.45B
Regeneron Pharmaceuticals is involved in inventing medicines for people with serious diseases, potentially competing with Biora in the biotech innovation space.
Biogen
BIIB
Mkt Cap28.94B
Biogen focuses on neuroscience and developing therapies for neurological diseases, which may intersect with Biora's therapeutic targets.
Abbvie
ABBV
Mkt Cap384.67B
AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, which could compete with Biora's products in overlapping areas of medicine.
Merck
MRK
Mkt Cap293.22B
Merck & Co., Inc. is a global healthcare company that produces medicines, vaccines, biologic therapies, and animal health products, potentially competing with Biora's range of therapeutic solutions.
Pfizer
PFE
Mkt Cap149.21B
Pfizer is a research-based global biopharmaceutical company with a wide range of products that could compete with Biora Therapeutics in various therapeutic areas.
Novo Nordisk
NVO
Mkt Cap201.95B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care, which may overlap with Biora's therapeutic interests.
Astrazeneca
AZN
Mkt Cap287.95B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, potentially competing with Biora in multiple therapeutic areas.

About

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Aditya P. Mohanty M.B.A.
Employees
58
Country
United States
ISIN
US74319F4046

Listings

STU
DE
4ZU.STU
MU
DE
4ZU.MU
OTC Link
US
BIORQ

0 Comments

Share your thoughts

FAQ

What is Biora Therapeutics stock price today?▼
The current price of 4ZU.MU is €3.06 EUR — it has decreased by -9.33% in the past 24 hours. Watch Biora Therapeutics stock price performance more closely on the chart.
What is Biora Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biora Therapeutics stocks are traded under the ticker 4ZU.MU.
Is Biora Therapeutics stock price growing?▼
4ZU.MU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Biora Therapeutics has showed a +0% increase.
How many employees does Biora Therapeutics have?▼
As of June 04, 2026, the company has 58 employees.
In which sector is Biora Therapeutics located?▼
Biora Therapeutics operates in the Other sector.
When did Biora Therapeutics complete a stock split?▼
Biora Therapeutics has not had any recent stock splits.
Where is Biora Therapeutics headquartered?▼
Biora Therapeutics is headquartered in San Diego, United States.